142 related articles for article (PubMed ID: 10344221)
21. Hormone-refractory prostate cancer in the Lobund-Wistar rat.
Pollard M; Suckow MA
Exp Biol Med (Maywood); 2005 Sep; 230(8):520-6. PubMed ID: 16118401
[TBL] [Abstract][Full Text] [Related]
22. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
24. Early manifestations of induced prostate tumors in Lobund-Wistar rats.
Pollard M; Luckert PH
Cancer Lett; 1992 Dec; 67(2-3):113-6. PubMed ID: 1483259
[TBL] [Abstract][Full Text] [Related]
25. High incidence and histogenesis of seminal vesicle adenocarcinoma and lower incidence of prostate carcinomas in the Lobund-Wistar prostate cancer rat model using N-nitrosomethylurea and testosterone.
Tamano S; Rehm S; Waalkes MP; Ward JM
Vet Pathol; 1996 Sep; 33(5):557-67. PubMed ID: 8885183
[TBL] [Abstract][Full Text] [Related]
26. Phenobarbital promotes multistage pulmonary carcinogenesis in MNU-inoculated L-W rats.
Pollard M; Luckert PH
In Vivo; 1997; 11(1):55-60. PubMed ID: 9067774
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.
Bentel JM; Pickering MA; Pollard M; Clements JA; Tilley WD
In Vitro Cell Dev Biol Anim; 1999; 35(10):655-62. PubMed ID: 10614877
[TBL] [Abstract][Full Text] [Related]
28. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system.
Pollard M; Luckert PH
Prostate; 1987; 11(3):219-27. PubMed ID: 3684782
[TBL] [Abstract][Full Text] [Related]
29. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
Ichikawa T; Lamb JC; Christensson PI; Hartley-Asp B; Isaacs JT
Cancer Res; 1992 Jun; 52(11):3022-8. PubMed ID: 1591718
[TBL] [Abstract][Full Text] [Related]
30. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
Vukanovic J; Passaniti A; Hirata T; Traystman RJ; Hartley-Asp B; Isaacs JT
Cancer Res; 1993 Apr; 53(8):1833-7. PubMed ID: 7682157
[TBL] [Abstract][Full Text] [Related]
31. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
32. Suppressive effects of dietary genistin and daidzin on rat prostate carcinogenesis.
Kato K; Takahashi S; Cui L; Toda T; Suzuki S; Futakuchi M; Sugiura S; Shirai T
Jpn J Cancer Res; 2000 Aug; 91(8):786-91. PubMed ID: 10965018
[TBL] [Abstract][Full Text] [Related]
33. Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancer.
Hartley-Asp B; Vukanovic J; Joseph IB; Strandgården K; Polacek J; Isaacs JT
J Urol; 1997 Sep; 158(3 Pt 1):902-7. PubMed ID: 9258116
[TBL] [Abstract][Full Text] [Related]
34. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
Vukanovic J; Isaacs JT
Cancer Res; 1995 Aug; 55(16):3517-20. PubMed ID: 7543015
[TBL] [Abstract][Full Text] [Related]
35. 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids.
Pham H; Ziboh VA
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):393-400. PubMed ID: 12589947
[TBL] [Abstract][Full Text] [Related]
36. Regulation of male sex hormone levels by soy isoflavones in rats.
Yi MA; Son HM; Lee JS; Kwon CS; Lim JK; Yeo YK; Park YS; Kim JS
Nutr Cancer; 2002; 42(2):206-10. PubMed ID: 12416261
[TBL] [Abstract][Full Text] [Related]
37. Soy, disease prevention, and prostate cancer.
Moyad MA
Semin Urol Oncol; 1999 May; 17(2):97-102. PubMed ID: 10332923
[TBL] [Abstract][Full Text] [Related]
38. Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with N-nitroso-N-methylurea and testosterone.
Pollard M; Luckert PH
J Natl Cancer Inst; 1986 Aug; 77(2):583-7. PubMed ID: 3461217
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143.
Homma Y; Kaneko M; Kondo Y; Kawabe K; Kakizoe T
J Natl Cancer Inst; 1997 Jun; 89(11):803-7. PubMed ID: 9182979
[TBL] [Abstract][Full Text] [Related]
40. Phytoestrogens and prostate cancer: possible preventive role.
Stephens FO
Med J Aust; 1997 Aug; 167(3):138-40. PubMed ID: 9269268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
